VYNE Therapeutics: Of The Company’s Current Report On Form 8k Filed With The Sec On December 17, 2025 Is Incorporated Herein By Reference, Completion Of Acquisition Or Disposition Of Assets, Results Of Operations And Financial Condition, Unregistered Sales Of Equity Securities, Material Modification To Rights Of Security Holders, Changes In Control Of Registrant, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Amendments To The Registrant’s Code Of Ethics, Or Waiver Of A Provision Of The Code Of Ethics, Regulation Fd Disclosure, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Yarrow Bioscience, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***